COMPAMIR
High-Purity Fact Pipeline
© 2026 COMPAMIR | Verified Intelligence
High-Purity Fact Pipeline
US Trade Representative (Jamieson Greer)
United States / Germany
June 2026
Verified: June 19, 2026
"The US Trade Representative has initiated a Section 301 investigation into Germany. The probe aims to determine if Germany is underpaying for innovative pharmaceutical products. The US claims this practice burdens American commerce and R&D funding. Germany's recent healthcare reforms aimed at cost-cutting have exacerbated tensions."
Author: Marcia Angell
This book provides a critical analysis of the pharmaceutical industry's business models, R&D funding, and the global pricing strategies that often lead to trade tensions between the US and other developed nations.
As an Amazon Associate, COMPAMIR earns from qualifying purchases.